Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
Tavexia Lifecare
Acquired Company
Meyonex Pharmaceuticals
Description
Tavexia Lifecare Limited has approved the acquisition of up to 60% equity in Meyonex Pharmaceuticals for ₹67.19 crore. The transaction, which involves the subscription of fresh equity shares, is aimed at expanding Tavexia's presence in the pharmaceutical sector. The deal will provide Meyonex with necessary liquidity for operational growth. Regulatory approvals are still pending as the companies proceed with documentation.
Fundz sees it the moment Tavexia Lifecare makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Meyonex Pharmaceuticals?
Meyonex Pharmaceuticals was acquired by Tavexia Lifecare. The deal was reported on October 7, 2026. Tavexia Lifecare is a company focused on healthcare and pharmaceutical developments. They aim to enhance patient care through innovative solutions. Tavexia Lifecare is privately held and operates in Biotechnology.
When did Tavexia Lifecare acquire Meyonex Pharmaceuticals?
Tavexia Lifecare's acquisition of Meyonex Pharmaceuticals was reported on October 7, 2026. Tavexia Lifecare Limited has approved the acquisition of up to 60% equity in Meyonex Pharmaceuticals for ₹67.19 crore. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Meyonex Pharmaceuticals do?
Meyonex Pharmaceuticals is a pharmaceutical company engaged in the development of various therapeutic drugs. They focus on delivering quality medications to enhance health outcomes. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.